at-13387 and Lymphoma--B-Cell

at-13387 has been researched along with Lymphoma--B-Cell* in 1 studies

Other Studies

1 other study(ies) available for at-13387 and Lymphoma--B-Cell

Article	Year
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss. American journal of hematology, 2019, Volume: 94, Issue:10 Topics: Adenine; Antibodies, Monoclonal, Humanized; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biological Products; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Immunotherapy, Adoptive; Isoindoles; Lymphocyte Depletion; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Neoplasms, Multiple Primary; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Recurrence; Salvage Therapy; Vincristine	2019

Article

Year

Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss.

American journal of hematology, 2019, Volume: 94, Issue:10

Topics: Adenine; Antibodies, Monoclonal, Humanized; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biological Products; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Immunotherapy, Adoptive; Isoindoles; Lymphocyte Depletion; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Neoplasms, Multiple Primary; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Recurrence; Salvage Therapy; Vincristine

2019